Summary data are provided for the whole United Kingdom. There were 41 776 adult patients alive on renal replacement therapy (RRT) in the UK at the end of 2005, a prevalence for adults of 694 pmp. Addition of 748 children under the age of 18 on RRT gives a total prevalence of 706 pmp. The more detailed analysis includes data on 37 534 patients from 65 of the 70 units which returned detailed data to the Registry: all in Northern Ireland, Scotland and Wales, and 45 of the 50 units in England. The annual increase in prevalence in the 38 renal units participating in the Registry since 2000 was 5.0%. There is substantial variation in the crude Local Authority area prevalence from 299 pmp to 1275 pmp. In general, areas with large ethnic minority populations had high standardized prevalence ratios (SPR). Nevertheless several Local Authority areas in South Wales (Methyr Tydfil, Swansea and Rhondda/Cynon/Taff) had a higher SPR than would be predicted from the local ethnic mix. Another group in North West England (Bury, Rochdale, Oldham and Salford), had a lower SPR than expected from the local ethnic mix. The median age of prevalent patients on RRT was 56.6 years, that of patients on HD 64.5 years, PD 59.2 years and transplanted patients 49.7 years. The median vintage of the whole RRT population was 5.1 years: that of transplanted patients was 9.8 years, HD patients 2.8 years and PD patients 2.1 years. The maximal prevalence rate (SPR) occurred in men (2270 pmp) in the 75-79-year age band and women (1144 pmp) in the 65-74-year age band. Of RRT patients in the UK, 45% had a transplant, 41.7% were on centre-based haemodialysis and 12% on peritoneal dialysis. The proportion of patients on home haemodialysis remained very small (1.2%) in spite of the recent NICE guidelines. The haemodialysis population is continuing to expand, mainly through growth in the proportion of patients undergoing dialysis in satellite units. The peritoneal dialysis population is continuing to contract in spite of the small but progressive rise in automated PD. The most common identifiable diagnosis in those under 65 was glomerulonephritis (18.0%) and in those over 65 it was diabetes (13.4%). One-year survival rates of prevalent patients in the different centres contributing to the UK Renal Registry are presented. The centres agreed to remove anonymity. There is no evidence of any significant differences in survival of prevalent patients between UK centres. The one-year survival of prevalent dialysis patients increased significantly from 1998 to 2004 in England (83.3% to 87.1% P ¼ 0.0001 for linear trend), Scotland (84.0% to 87.0% P ¼ 0.023 for linear trend) and Wales (83.4% to 86.1% P ¼ 0.027 for linear trend). The test for non-linearity in this trend (indicating that there has been a large increase which is now tailing off) was significant for England and Wales.
Introduction
The prevalence data presented are from the whole United Kingdom. In 2005, the UK Renal Registry received complete returns from all five units in Wales, all five units in Northern Ireland and 90% of the units in England. Data from all 10 units in Scotland were obtained from the Scottish Renal Registry. In addition summary data were obtained separately from the five remaining English units not currently returning to the Registry, to enable accurate calculation of prevalence and modality used.
Extrapolation from Registry data to derive other information relating to the whole UK was still necessary and these results must still be viewed with a little caution, although estimates become more reliable as coverage increases. The proportion of the population aged over 65 years was similar in the fully covered population (defined below, based on Local Authority (LA) areas whose population was thought to be fully covered by participating units) compared with the general population of England and Wales. The proportion from ethnic minority groups was lower in the fully covered population at 8.1% compared with 9.0% in the total population, because some areas not reporting to the Registry have catchments with high ethnic minority populations.
For comparisons between renal units and between local areas fully covered by the Renal Registry, the data from the Registry are fully valid. Data on children and young adults can be found in Chapter 13.
All adult patients receiving renal replacement therapy in the United Kingdom (31 December 2005)
There were 41 776 adult patients receiving RRT in the United Kingdom at the end of 2005, giving a total population prevalence for adults of 694 pmp (Table 4 .1). Addition of the 748 children under age 18 on RRT (Chapter 13) gives a total prevalence of 706 pmp.
In those renal units continuously reporting for the last 6 years there was an average rise in prevalence from year to year of between 4.2% and 6.5%.
Prevalent patients by renal unit on 31 December 2005
For 2005, detailed data on prevalent patients were returned from 45 of the 50 renal units in England, all five units in Wales, all five units in Northern Ireland and all 10 units in Scotland, a total of 37 534 patients. The number of prevalent patients in each renal unit and the distribution of their treatment modalities are shown in Table 4 .2.
There is a wide variation in the number of prevalent patients in each unit and in the distribution of these patients in the different treatment modality categories. This is due to many factors including geography, local population density, age distribution, ethnic composition and social deprivation index of that population. Local facilities and preferences also play a role in determining the modality distribution. Some of these will be discussed later in the chapter. However, another major factor is whether or not the renal unit is also a transplant centre. The 23 renal units which are also transplant centres tend to have a higher proportion of transplant patients under follow up compared with the other 42 units, but are also the larger dialysis units. The transplant/dialysis ratio is markedly higher in transplant centres than in other renal units (1.17 vs 0.46: P < 0.001). The wide variability of this ratio both in transplanting (0.58-2.65) and non-transplanting (0.01-1.2) renal units suggests considerable variation in policies for follow up of transplanted patients; some transplant centres continue to follow up the patients they transplant for other renal units, others transfer them back to their parent unit but at variable times post transplant and some renal units do not follow up any transplant patients.
Changes in prevalence 2000-2005
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The growth in prevalent patient numbers in the UK since 1982 is shown in Figure 4 .1.
The total percentage increase in number of prevalent patients in the 38 renal units who have returned data continuously from 2000 to 2005 was 27.8%. The rate of increase was similar in England (27.6%), Scotland (28.6%) and Wales (27.9%) and fairly uniform over the time span, varying between 4.2 and 6.5% per year (Table 4 .4).
Local Authority prevalence
The prevalence of RRT and standardized prevalence ratios in those Local Authorities with complete coverage in 2005 are shown in Table 4 .5.
Standardized prevalence ratios

Methods
The methods of calculating the standardized rate ratio are described in detail in Appendix D (www.renalreg.org). In summary, age-and gender-specific prevalences were first calculated using the available registry data on the number of prevalent patients for the covered area in England, Wales, Scotland and Northern Ireland and the data on the age and gender breakdown of the population of each Local Authority area obtained from the 2001 census data from the Office of National Statistics (ONS). These age and gender prevalences were then used to calculate the expected prevalence for each LA area. The age and gender standardised ratio is therefore equal to (observed prevalence)/(expected prevalence).
A ratio of 1 indicates that the LA area's prevalence was as expected if the age/gender rates found in the total covered population applied to the LA area's population structure; a level above 1 indicates that the observed prevalence is greater than expected given the LA area's population structure; if the lower confidence limit was above 1 this is statistically significant at the 5% level. The converse applies to standardised prevalence rate ratios under one.
Prevalence estimates of RRT in relatively small populations such as those covered by individual Primary Care Trusts incur wide confidence intervals for any observed frequency. To enable assessment of whether an observed prevalence rate differs significantly from the national average, Figures 4.2 and 4.3 have been included. For any size of population (X axis), the upper and lower 95% confidence limits (dotted lines) around the national average prevalence can be read from the Y axis. Any observed prevalence for renal failure outside these limits is significantly different from the national average. Thus for a population of 50 000, an observed prevalence outside the limits of 470-930 pmp is significantly different, whilst for a population of 500 000 the limits are 625-770 pmp.
Results
There were substantial variations in the crude LA area prevalence from 299 (Bury) to 1275 pmp (Carrickfergus). As discussed earlier, local authorities with small populations have wide confidence limits for standardised prevalence rate (SPR), such that the interpretation of an individual year may be difficult. Nevertheless the annual standardized prevalence rate is inherently more stable than the annual standardized acceptance.
Geographical considerations and ethnicity are the major factors underlying the variation in SPR. There were 33 local authority areas with a significantly low SPR, 123 with a normal SPR and 51 with a significantly high SPR. The geographical distribution of these is summarised in Table 4 .6. The North West (P < 0.0001) and the South East of England (P ¼ 0.03) had a significantly higher proportion of areas with a low SPR, whilst in London, Wales, Scotland and Northern Ireland, the proportion was significantly lower (P ¼ 0.03 in all cases). Conversely, London (P < 0.0001) and Northern Ireland (P ¼ 0.048) had a significantly higher proportion of areas with a high SPR, whilst in the North East (P ¼ 0.04) and the North West of England (P ¼ 0.008), the proportion was significantly lower. Although overall areas with a high SPR had significantly higher ethnic minority populations than areas with significantly low or normal SPRs (P < 0.0001) (Figure 4 .4), in some areas such as South Wales, ethnicity does not seem to be a major factor.
The relationship between the ethnic composition of a LA area and its SPR is further demonstrated in Figure 4 .5, which shows the relationship between ethnicity and SPR for all local authorities with available data. A small group of local authority areas in Wales have a higher SPR than might be predicted from the local ethnic mix. 
Vintage of prevalent patients
Age of prevalent patients
The median age of prevalent patients on RRT was 56.6 years (Table 4.8). The age profile is markedly different in patients on dialysis than in transplanted patients. The median age of patients on HD (64.5 years) was higher than that of patients on PD (59.2 years) and substantially higher than that of transplanted patients (49.7 years). There were wide variations in median age between renal units for the whole RRT population (50.8-67.7 years). The major determinant of the median age of the prevalent RRT population is the ratio of the number of transplant and dialysis patients in that population (r ¼ À0.764, P < 0.0001).
The differing age distributions of transplant and dialysis patients are well illustrated in Figure 4 .6, the maximum prevalence of dialysis patients being almost The figures for Leicester, Reading and Oxford are misleading as there has been a redistribution of catchment areas related to these units. 
Ethnicity
Thirty-six of the 65 centres submitting data to the Registry provided ethnicity data that were at least 90% complete. The data for centres with less than 50% returns for ethnicity are excluded from Table 4 .9. Centres in Scotland are not required to report ethnicity to the Scottish Registry.
Primary renal disease
In the previous 2 years' reports, the statement with the help of table indicating that diagnosis code GN histologically not examined (EDTA code 10) had been included in the 'Uncertain' group for analysis, was incorrect. Approximately 1000 patients had been incorrectly allocated to the glomerulonephritis category. Table 4 .10 this year, has now been corrected. The previous years' data has also been retrospectively analysed to this grouping and the data this year show no change and is consistent with the reports prior to 2004. The most common specific diagnosis overall remains glomerulonephritis, in contrast to the pattern in incident patients in whom diabetes predominates. This reflects different survival and different ages of the patients with these diagnoses. There are age-related differences. The prevalence of the aetiology uncertain/glomerulonephritis-not biopsy proven category is much greater in those aged over 65 years (27.7% vs 19.8%). In addition, diabetes (13.4%) [not glomerulonephritis (9.9%)] was the most common specific diagnosis in those over 65 years. The male:female ratio was significantly greater than unity for most primary renal diseases, but only marginally for polycystic kidney disease and pyelonephritis. The ratio for polycystic kidney disease is similar to that in incident patients and the possible underlying reasons were discussed in Chapter 3. The ratio for pyelonephritis is markedly different in prevalent (1.1) and incident patients (1.7). This is a consistent finding and may indicate poorer survival on RRT of males with this diagnosis. The distribution of patients between the modalities is also heavily influenced by primary renal diagnosis ( Table 4 .11). Patients with pyelonephritis, polycystic kidney disease and glomerulonephritis are much more likely to have been transplanted than patients with diabetes and those with renal vascular disease. The differences are even more marked in patients over the age of 65.
Diabetes
The median age of all prevalent diabetic RRT patients (58.8 years) is slightly higher than that of non-diabetics (56.2 years), patients with Type 1 disease being considerably younger (52.8 years) than those with Type 2 disease (66.6 years) ( 
Modalities of treatment
The most common treatment modality is transplantation (45.0%), closely followed by the proportion on centre-based HD (41.7%) as shown in Figure 4 .9. The proportion of patients on home HD remains very small (1.2% of RRT) in spite of the recent NICE guidelines.
Transplantation is the predominant treatment modality in patients less than 65 years old and haemodialysis in those 65 or older (Table 4 .14). The proportions are similar in all of the UK countries except a small preference in favour of HD over PD in Northern Ireland, particularly in older patients.
Haemodialysis is increasingly prominent with increasing age at the expense of transplantation. The proportion of each age group treated by PD remains fairly stable across the whole age spectrum (Figure 4 .10). 
Haemodialysis
The proportion of dialysis patients on HD in the UK was 78% and higher in those over 65 years old than in younger patients (83% vs 74%). The proportions varied widely between renal units but the same pattern of age distribution was maintained in all but five units (Dorset, Ulster, Inverness, Dumfries & Galloway and Wolverhampton, Figure 4 .11). A slightly larger percentage of the male dialysis population (78.7%) In some centres local coding of RRT modality is such that the Registry could not differentiate between CAPD and cycling PD. In these centres all PD patients are included as CAPD disconnect. Thus the proportion of PD patients on cycling PD is a slight underestimate. were on HD than of the female dialysis population (76.7%: P < 0.001).
The proportion receiving HD in satellite units varied. Twenty-nine units had no satellite haemodialysis whilst 12 units dialysed more than 50% of their haemodialysis patients in satellites (Figure 4 .12). Satellite HD amounted to 34.5% of total HD activity. Twenty-one units had no home HD programme. In the 44 units which did offer home HD, the proportion of HD patients treated by this modality ranged from 0.6% to 11.1%. Overall only 2.7% were on home HD. Twelve units had home HD programmes amounting to more than 5% of total HD activity.
Peritoneal dialysis
The proportion of prevalent dialysis patients on PD varies widely ranging from 2.4% (one patient) in Ulster to 38.2% in Ipswich (Figure 4 .13). Overall 23.3% of the female dialysis population were on PD compared with 21.2% of the male dialysis population (P < 0.001). The overall male to female ratio was 1.4 but there was marked variation between centres, the ratio varying from 0.6 to 5.0.
CAPD using disconnect systems remains the most common PD mode (62.0% of all patients on PD). The use of automated PD (APD) is continuing to increase and now comprises 32.2% of all PD treatments. However, the use of APD varies widely between units, ranging from 0% to 100% of all PD treatments (Figure 4 .14). Treatment for six or more nights weekly is the norm, but many units use less frequent treatments on an occasional basis and one unit (Guys), exclusively. Use of connect systems remains very uncommon (3.6% of all treatments).
Change in treatment modality 1997-2005
The pattern of modality usage in prevalent RRT patients is still continuing to change (Figure 4 .15). The proportion of RRT patients on haemodialysis continues to increase at the expense of a decreasing proportion of peritoneal dialysis and transplant patients. It should be noted though that the figures from each year are not strictly comparable since the number of units contributing to the Registry has increased successively.
Within the dialysis population, the proportion of patients undergoing haemodialysis in traditional hospital based units has reached a plateau, whilst the proportion dialysing in satellite units continues to grow. There is a progressive fall in the proportion on disconnect CAPD. The proportion on automated PD continues its slow rise. The use of 'standard' or 'connect' CAPD has virtually disappeared. In spite of NICE guidance, the proportion on home haemodialysis remains very low and static. 
RRT in UK in 2005 vii43
The trends in change of proportions of patients on each modality of treatment since 1998 are shown in Figure 4 .16.
Survival of patients established on RRT
This section analyses the 1 year survival rates in the different centres contributing to the UK Renal Registry. This year, with the agreement of all UK clinical directors, centre anonymity has been removed. These are raw data that require very cautious interpretation if legitimate centre comparisons are to be attempted. The Registry can adjust for the effects of the different age distributions of the patients in different centres, but lacks sufficient data from participating centres to enable adjustment for comorbidity and ethnic origin, which have been demonstrated to have a major impact on outcome. With this lack of information on case mix, it is difficult to interpret any apparent difference in survival between centres.
All patients who had been established on RRT for at least 90 days on 1 January 2005 were included in this analysis. The patients in the transplant cohort have all been established with a transplant for at least 6 months.
As discussed in previous reports, comparison of survival of prevalent dialysis patients between centres is complex. Survival of prevalent dialysis patients can be studied with or without censoring at transplant. When a patient is censored at transplantation, the patient is considered as alive up to the point of transplantation, but the patient's status post-transplant is not considered. Therefore a death following transplantation is not taken into account in calculating the survival figure. It could induce differences between those renal units with a high transplant rate and those with a low transplant rate, especially in younger patients where the transplant rate is highest. The differences are likely to be small due to the low post-transplantation mortality rate and the relatively small proportion of patients being transplanted in a given year compared to the whole dialysis population (usually less than 7% of the total dialysis population). To estimate the potential differences, the results for individual renal units were compared with and without censoring at transplant. The results are shown in Table 4 .15. Overall there is a 0.5% increase in survival using the censored data. With such small differences only the censored results have been quoted throughout the rest of this chapter.
Another potential source of error in comparing survival of dialysis patients in different renal centres, especially younger patients, is the differing transplant rates between centres. Those with a high transplant rate have removed more of the fitter patients from dialysis and are left with a higher risk population on dialysis.
The one-year death rate per 100 patient years is shown in Table 4 .16 and one-year survival of established prevalent RRT patients in Table 4 .17.
In Figure 4 .17 the survival of prevalent dialysis patients for each age band is shown.
One-year survival of prevalent dialysis patients
The 1-year survival of dialysis patients in each centre is shown in (P ¼ 0.40). No centres had adjusted one year survival significantly below the national mean. This is consistent with a previous Registry neural network analysis of survival in UK prevalent patients which indicates that the difference in survival between centres is related to differences in patient characteristics, rather than a true centre effect [1] . 
